In our current study, we found that in high dose LPS (30 mg/kg) induced severe ARDS, depletion of RIP3 by reducing MLKL decreased necroptosis and subsequently ameliorated the lung injury, increased body temperature, improved survival rate, and decreased the expression of IL-1α/β and IL-6. The gene discussed is RIPK3; the disease is acute respiratory distress syndrome.